Market revenue in 2023 | USD 3.7 million |
Market revenue in 2030 | USD 5.7 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Oral |
Fastest growing segment | Enteral |
Historical data | 2016 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oral, Enteral |
Key market players worldwide | Nestle SA, Danone SA, Abbott Laboratories, Reckitt Benckiser Group PLC, Relief Therapeutics Holding SA, Ajinomoto Co Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account